Formulation and Evaluation of Medicated Lollipop of Cetirizine for Improved Patient Compliance
The present study focuses on the formulation and development of a medicated lollipop containing cetirizine hydrochloride, a second-generation antihistamine commonly used in the treatment of allergic conditions such as rhinitis and urticaria. The objective was to design a patient-friendly, palatable dosage form suitable for pediatric and geriatric populations, offering ease of administration and improved compliance. Cetirizine was selected for its low dosage requirement, rapid onset of action, and favorable pharmacokinetics. The medicated lollipops were prepared using the heating and congealing molding technique with a sugar-based matrix, incorporating sweeteners, flavoring agents, and taste-masking excipients to improve palatability. Various formulations were evaluated for physical characteristics such as appearance, hardness, weight variation, drug content uniformity, and in vitro drug release. The optimized formulation demonstrated acceptable mechanical properties, uniform drug distribution, and a sustained drug release profile, while effectively masking the bitter taste of cetirizine. This study concludes that cetirizine lollipops are a promising alternative to conventional dosage forms particularly for pediatric allergy management, combining therapeutic efficacy with enhanced patient compliance.
Authors
- ANIL PAWAR
- Mathpati Pratiksha
- V. S. Kadam
Institutions
- Sanskriti Samvardhan Mandal (IN)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-21
- DOI
- https://doi.org/10.5281/zenodo.24415283
- Primary Topic
- Advanced Drug Delivery Systems
- Type
- article
- Field-Weighted Citation Impact
- 0.00